Ikarian Capital’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$230K	Hold	22,166	–	–	0.04%	79
2025 Q1	$292K	Sell	22,166 -30,000	-58%	-$395K	0.04%	88
2024 Q4	$934K	Sell	52,166 -27	-0.1%	-$484	0.13%	69
2024 Q3	$841K	Sell	52,193 -190,177	-78%	-$3.07M	0.12%	60
2024 Q2	$6.55M	Buy	+242,370	New	+$6.55M	1.14%	15